MedPath

GENENTECH INC

GENENTECH INC logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

108

Active:90
Completed:5

Trial Phases

4 Phases

Phase 1:82
Phase 2:4
Phase 3:6
+1 more phases

Drug Approvals

7

NMPA:5
FDA:2

Drug Approvals

Trastuzumab Injection

Product Name
赫赛汀
Approval Number
国药准字J20170037
Approval Date
May 11, 2017
NMPA

Trastuzumab Injection

Product Name
赫赛汀
Approval Number
J20170037
Approval Date
May 11, 2017
NMPA

Trastuzumab Injection

Product Name
赫赛汀
Approval Number
S20160056
Approval Date
Dec 9, 2016
NMPA

Trastuzumab Injection

Product Name
注射用曲妥珠单抗
Approval Number
S20150068
Approval Date
Dec 23, 2015
NMPA

Trastuzumab Injection

Product Name
赫赛汀
Approval Number
S20150067
Approval Date
Dec 23, 2015
NMPA

Clinical Trials

Distribution across different clinical trial phases (95 trials with phase data)• Click on a phase to view related trials

Phase 1
82 (86.3%)
Phase 3
6 (6.3%)
Phase 2
4 (4.2%)
phase_1_2
2 (2.1%)
Phase 4
1 (1.1%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath